The underlying mechanism is that SLC39A6 and cellular zinc could active the PI3K/Akt and MAPK/ERK signaling pathways, thus promoting the occurrence and development of ESCC (43). Here, SLC39A6 is linked to esophageal squamous cell carcinoma.